Co-Diagnostics, Inc. is trading 5.5% down at $5.88 in pre-market, extending sharp volatility following an S-3 resale registration filing.
- Shares have fluctuated significantly since late May after an effective registration for up to 4.94 million shares and warrants triggered heavy selling and a subsequent rebound.
- Todayβs downward move reflects continued digestion of the share overhang and profit-taking following recent double-digit price moves.